Wednesday, July 12, 2017
F.D.A. Deal Would Relax Rules on Reporting Medical Device Problems
F.D.A. Deal Would Relax Rules on Reporting Medical Device Problems-nytimes: Makers of cardiac defibrillators, insulin pumps, breast implants and other medical devices might be able to delay reporting dangerous malfunctions to the Food and Drug Administration under an agreement heading for a vote in Congress.